S

Sino Biopharmaceutical

Sustainability Report and Carbon Intensity Rankings

Is Sino Biopharmaceutical doing their part?

Their DitchCarbon score is 54

Sino Biopharmaceutical has a DitchCarbon Score of 54, indicating a moderate level of sustainability in their operations. This score reflects the company’s carbon intensity, which is a measure of the greenhouse gases emitted relative to the value they generate. A score of 54 suggests there is room for improvement in reducing carbon intensity and enhancing their environmental performance.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

Sino Biopharmaceutical operates in the industrial manufacturing sector, which has a very low carbon intensity ranking. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Unknown

High

Very high

Sino Biopharmaceutical, located in Western Australia, operates in a region with an unknown carbon intensity rating. This uncertainty makes it challenging to assess the direct impact of the country’s energy mix on the company’s sustainability efforts.

Unlock 30+ emissions intelligence data points

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

Unlock 30+ emissions data points on Sino Biopharmaceutical

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

12.71%

...this company is doing 12.71% better in emissions than the industry average.

Sino Biopharmaceutical Limited, founded in 2000, is situated on Hong Kong Island at 1 Harbour Road, Hong Kong. Operating within the pharmaceuticals industry, the company specializes in the development and manufacturing of medical products. It is a key player in the Asian pharmaceutical market, offering innovative healthcare solutions.

Compare Sino Biopharmaceutical with other companies in the same industry –>

emission intelligence's platform recommendations for Sino Biopharmaceutical

Sino Biopharmaceutical should explore opportunities for fuel switching in transportation and operations to potentially reduce their emissions by 15%.

Bad news, Sino Biopharmaceutical hasn't committed to SBTi goals yet.

Sino Biopharmaceutical has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is either in the process of setting or has not publicly disclosed its goals for reducing greenhouse gas emissions in line with climate science.

Not participating

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Other company reports in this industry

Looking for a specific company?

Search our company directory or contact us for custom data requests.

S

Sino Biopharmaceutical

Sustainability Report and Carbon Intensity Rankings

Is Sino Biopharmaceutical doing their part?

Their DitchCarbon score is 54

Industry emissions intensity

Very low

Low

Medium

High

Very high

Location emissions intensity

Very low

Low

Unknown

High

Very high

Unlock 30+ emissions intelligence data points

Unlock 30+ emissions data points on Sino Biopharmaceutical

...this company is doing 12.71% better in emissions than the industry average.

emission intelligence's platform recommendations for Sino Biopharmaceutical

Bad news, Sino Biopharmaceutical hasn't committed to SBTi goals yet.

Claim this profile

Our methodology

Other company reports in this industry

Looking for a specific company?

Quicklinks

Resources

Get in touch